openPR Logo
Press release

DASGIP improves gassing options at pilot scale and in industrial biotechnology

08-16-2007 02:04 PM CET | Science & Education

Press release from: DASGIP AG

/ PR Agency: Biotech Consulting
Juelich, 16th August 2007. DASGIP AG, a leading manufacturer of parallel bioreactor systems, expands its range of gassing solutions for fermentation and cell cultivation by introducing the new modules MX4/1 and MF4. MX4/1 supplies reactors up to pilot scale, while MF4 has been designed specifically to meet the requirements of industrial biotechnology.

DASGIP’s new gas mixing system MX4/1 complements their best-selling single module MX4/4. Both products provide a mass flow controlled mixture of air, oxygen, carbon dioxide and nitrogen. While MX4/4 serves four separate culture vessels, MX4/1 pipes the gas mixture into one reactor at a rate of up to 2,000 standard litres per hour (sL/hr). MX4/1 is thereby ideally suited for gassing requirements at pilot scale. Electronic mass flow controllers and set-points at each outlet enable precise and individual adjustment of oxygen and carbon dioxide concentrations, offering more reproducible results. Users can now also define the mixture components of incoming gases, e.g. artificial oxygen composed of 90% oxygen and 10% nitrogen in order to use gas mixtures according to their security standards.

The new DASGIP MF4 has been developed for processes requiring unconventional gasses such as methane and carbon monoxide in biofuel development. MF4 provides mass flow controlled gassing up to 2,000sL/hr for four parallel channels and users are free to select any four input gasses to suit their needs. Independent gas leads ensure different gases can be combined even though they would normally react with each other.

Both gas mixing appliances as well as the MF4 are equipped with sensitive pressure sensors to ensure gassing is automatically stopped when excess pressure occurs. This ensures a high measure of workplace and production safety when handling glass vessels and bags.
With its new products MX4/1 and MF4, the market leading MX4/4, and the gassing module RX2/4, DASGIP AG serves a broad range of users and requirements in cell cultivation and fermentation.

DASGIP will be demonstrating its new gassing systems at the Biotechnica 2007 in Hanover, Germany (9 - 11 October 2007, booth G25, hall 9).

DASGIP AG
Rudolf-Schulten-Str. 5
D - 52428 Jülich
Phone: +49 (0) 2461 980 0
info@dasgip.de
www.dasgip.com

Contact:
Jennefer Vogt
DASGIP AG
Tel: +49 (0) 2461 980 118
j.vogt@dasgip.de

Dr. Holger Bengs
Biotech Consulting
Tel: +49 (0) 69 61 994 273
info@holgerbengs.de

DASGIP AG develops and manufactures technologically advanced Parallel Bioreactor Systems for the cultivation of microbial and mammalian cells at bench top and pilot scale. Process engineers, scientists and product developers from biotechnological, pharmaceutical and chemical companies as well as research institutions use DASGIP Parallel Bioreactor Systems for their biotechnological processes and benefit from increased productivity, high reproducibility, and ease of scale up, resulting in accelerated product development cycles.
DASGIP is located in Juelich (Germany) and Shrewsbury MA (USA).

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DASGIP improves gassing options at pilot scale and in industrial biotechnology here

News-ID: 25936 • Views:

More Releases from DASGIP AG

DASGIP presents product innovations during Biotechnica 2007
Juelich, 4th October 2007. DASGIP AG, leading manufacturer of parallel bioreactor systems, will present a number of innovations at their booth during Biotechnica in Hanover. OD4, an online monitoring module for optical density, offers fast and accurate measurement of biomass and cell growth in up to four vessels. OD4 utilizes small sensors and a proprietary signal processing algorithm to reduce the signal disturbance caused by gas bubbles in the media. These
DASGIP AG optimizes Biofuel production
Juelich, 5th September 2007. DASGIP AG, a leading manufacturer of parallel bioreactor systems, has optimized its technology for the process development of anaerobic micro-organisms via their parallel design. Through this type of parallel control and monitoring, a more efficient development of biofuels like bioethanol is facilitated. DASGIP will present these fermentation control systems during the Biotechnica 2007 in Hanover. Bioethanol is produced by a variety of micro-organisms under anaerobic conditions,

More Releases for MX4/1

Adrian Gabriel Dumitru's 1+1=1: Beyond the Secrets of Beautiful Relationships
In 1+1=1: Beyond the Secrets of Beautiful Relationships , Adrian Gabriel Dumitru reflects deeply on the transformative nature of love and what it means to lose oneself in another. This heartfelt collection of personal essays explores the emotional surrender that takes place when two souls merge into one-an experience both ecstatic and unsettling. Available now on Amazon [https://www.amazon.com/beyond-secrets-beautiful-relationships-ebook/dp/B0DN6VLFB8], Apple Books [https://books.apple.com/us/book/1-1-1-beyond-the-secrets-of-beautiful-relationships/id6737967487], and Google Play [https://play.google.com/store/books/details/Adrian_Gabriel_Dumitru_1_1_1?id=tqkvEQAAQBAJ] Image: https://www.abnewswire.com/upload/2025/05/29d77a4bd771786c9c00dc6161d82077.PNG Dumitru paints love not as a
1 Year
New Horizon Gurukul School (NHG), Bangalore, is one of the best CBSE schools in Marathahalli. It is well known for its academic excellence and holistic student development. A unique combination of experienced educators and dedicated mentors, the faculty at New Horizon Gurukul is committed to shaping each student's future. The school offers education from Pre-Kindergarten (KG) through Grade 12. It follows the CBSE (Central Board of Secondary Education) curriculum and provides
Global 1-Ethynyl-1-Cyclohexanol Market Insights, Forecast to 2030
The global 1-Ethynyl-1-Cyclohexanol market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global 1-Ethynyl-1-Cyclohexanol market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global 1-Ethynyl-1-Cyclohexanol Market.
Isaac Mashman Announces Mashman Global's Upcoming "1:1 Pledge"
In December of 2023, businessman Isaac Mashman announced his intent to launch a nonprofit initiative 'Mashman Global.' As ideas are set into place and planning is underway, he is proud to provide an early insight into what he is calling "Mashman Global's 1:1 Pledge." The premise behind this is simple and aligns with his strong sense of nationalism as well as international concerns. This visionary initiative pledges that for every
1, 1, 1-Trichloro-3, 3, 3-trifluoroacetone Market Analysis,Demand,Trends and For …
Global Info Research announces the release of the report "Global 1, 1, 1-Trichloro-3, 3, 3-trifluoroacetone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Glucagon Like Peptide-1 (GLP-1) Agonists Market - key players covered:GSK, Sanof …
Los Angeles, United State, –The report titled Global Glucagon Like Peptide-1 (GLP-1) Agonists Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer